Form 4: BioMarin Director Richard A. Meier Acquires 6,650 Shares of Common Stock

Director Richard A. Meier acquired 6,650 shares of BioMarin Pharmaceutical Inc. common stock on May 20, 2025, through restricted stock units.

Summary

• Richard A. Meier, a director of BioMarin Pharmaceutical Inc., reported a transaction on May 20, 2025.
• He acquired 6,650 shares of common stock through the grant of restricted stock units.
• The price per share for the acquisition was $0.
• Following the transaction, Meier directly owns 127,426 shares of BioMarin common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director, which doesn't inherently indicate positive or negative sentiment about the company's performance.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, engages in a transaction involving the company's securities. It provides transparency to the market regarding insider activity.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as insider buying is often viewed favorably.

Key Dates

Keywords

BioMarin, Director, Share Acquisition, Form 4, Restricted Stock Units, BMRN, Insider Trading